These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 36264285)

  • 61. Targeted DNA and RNA Sequencing of Paired Urothelial and Squamous Bladder Cancers Reveals Discordant Genomic and Transcriptomic Events and Unique Therapeutic Implications.
    Hovelson DH; Udager AM; McDaniel AS; Grivas P; Palmbos P; Tamura S; Lazo de la Vega L; Palapattu G; Veeneman B; El-Sawy L; Sadis SE; Morgan TM; Montgomery JS; Weizer AZ; Day KC; Neamati N; Liebert M; Keller ET; Day ML; Mehra R; Tomlins SA
    Eur Urol; 2018 Dec; 74(6):741-753. PubMed ID: 30033047
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Treatment outcome according to genetic tumour alterations and clinical characteristics in digestive high-grade neuroendocrine neoplasms.
    Elvebakken H; Venizelos A; Perren A; Couvelard A; Lothe IMB; Hjortland GO; Myklebust TÅ; Svensson J; Garresori H; Kersten C; Hofsli E; Detlefsen S; Vestermark LW; Knappskog S; Sorbye H
    Br J Cancer; 2024 Sep; 131(4):676-684. PubMed ID: 38909137
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Genetic characterisation of sarcomatoid carcinomas reveals multiple novel actionable mutations and identifies
    Ding Y; Shao Y; Na C; Yin JC; Hua H; Tao R; Jiang Y; Hu R; He X; Miao C; Zhu D; Zhang Z
    J Med Genet; 2022 Jan; 59(1):10-17. PubMed ID: 33115932
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Comparison of the somatic genomic landscape between central- and peripheral-type non-small cell lung cancer.
    Wang L; Diao M; Zhang Z; Jiang M; Chen S; Zhao D; Liu Z; Zhou C
    Lung Cancer; 2024 Jan; 187():107439. PubMed ID: 38113653
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Clinicopathologic and Molecular Characterization of Anorectal Neuroendocrine Carcinomas Reveals Human Papillomavirus, p53, and c-Myc as Alternative Mechanisms of Carcinogenesis.
    Cox AJ; Crowe WE; Yang Q; Zhang B; Oltvai ZN; Liao X
    Mod Pathol; 2023 Nov; 36(11):100295. PubMed ID: 37517480
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Clinicopathologic features of neuroendocrine carcinomas of the stomach: appraisal of small cell and large cell variants.
    Matsui K; Jin XM; Kitagawa M; Miwa A
    Arch Pathol Lab Med; 1998 Nov; 122(11):1010-7. PubMed ID: 9822131
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Intertumor heterogeneity of non-small-cell lung carcinomas revealed by multiplexed mutation profiling and integrative genomics.
    Tan DS; Camilleri-Broët S; Tan EH; Alifano M; Lim WT; Bobbio A; Zhang S; Ng QS; Ang MK; Iyer NG; Takano A; Lim KH; Régnard JF; Tan P; Broët P
    Int J Cancer; 2014 Sep; 135(5):1092-100. PubMed ID: 24482041
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Immunohistochemical and mutational analysis of c-kit in gastrointestinal neuroendocrine cell carcinoma.
    Ishikubo T; Akagi K; Kurosumi M; Yamaguchi K; Fujimoto T; Sakamoto H; Tanaka Y; Ochiai A
    Jpn J Clin Oncol; 2006 Aug; 36(8):494-8. PubMed ID: 16844734
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Prognostic Factors across Poorly Differentiated Neuroendocrine Neoplasms: A Pooled Analysis.
    Centonze G; Maisonneuve P; Prinzi N; Pusceddu S; Albarello L; Pisa E; Barberis M; Vanoli A; Spaggiari P; Bossi P; Cattaneo L; Sabella G; Solcia E; La Rosa S; Grillo F; Tagliabue G; Scarpa A; Papotti M; Volante M; Mangogna A; Del Gobbo A; Ferrero S; Rolli L; Roca E; Bercich L; Benvenuti M; Messerini L; Inzani F; Pruneri G; Busico A; Perrone F; Tamborini E; Pellegrinelli A; Kankava K; Berruti A; Pastorino U; Fazio N; Sessa F; Capella C; Rindi G; Milione M
    Neuroendocrinology; 2023; 113(4):457-469. PubMed ID: 36417840
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Gene Expression Profiling of Lung Atypical Carcinoids and Large Cell Neuroendocrine Carcinomas Identifies Three Transcriptomic Subtypes with Specific Genomic Alterations.
    Simbolo M; Barbi S; Fassan M; Mafficini A; Ali G; Vicentini C; Sperandio N; Corbo V; Rusev B; Mastracci L; Grillo F; Pilotto S; Pelosi G; Pelliccioni S; Lawlor RT; Tortora G; Fontanini G; Volante M; Scarpa A; Bria E
    J Thorac Oncol; 2019 Sep; 14(9):1651-1661. PubMed ID: 31085341
    [TBL] [Abstract][Full Text] [Related]  

  • 71. APC mutations in human colon lead to decreased neuroendocrine maturation of ALDH+ stem cells that alters GLP-2 and SST feedback signaling: Clue to a link between WNT and retinoic acid signalling in colon cancer development.
    Zhang T; Ahn K; Emerick B; Modarai SR; Opdenaker LM; Palazzo J; Schleiniger G; Fields JZ; Boman BM
    PLoS One; 2020; 15(10):e0239601. PubMed ID: 33112876
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Integrative genomic profiling of large-cell neuroendocrine carcinomas reveals distinct subtypes of high-grade neuroendocrine lung tumors.
    George J; Walter V; Peifer M; Alexandrov LB; Seidel D; Leenders F; Maas L; Müller C; Dahmen I; Delhomme TM; Ardin M; Leblay N; Byrnes G; Sun R; De Reynies A; McLeer-Florin A; Bosco G; Malchers F; Menon R; Altmüller J; Becker C; Nürnberg P; Achter V; Lang U; Schneider PM; Bogus M; Soloway MG; Wilkerson MD; Cun Y; McKay JD; Moro-Sibilot D; Brambilla CG; Lantuejoul S; Lemaitre N; Soltermann A; Weder W; Tischler V; Brustugun OT; Lund-Iversen M; Helland Å; Solberg S; Ansén S; Wright G; Solomon B; Roz L; Pastorino U; Petersen I; Clement JH; Sänger J; Wolf J; Vingron M; Zander T; Perner S; Travis WD; Haas SA; Olivier M; Foll M; Büttner R; Hayes DN; Brambilla E; Fernandez-Cuesta L; Thomas RK
    Nat Commun; 2018 Mar; 9(1):1048. PubMed ID: 29535388
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Expression of p53 and Rb reveal subtypes of gastric neuroendocrine carcinoma with distinct prognosis.
    Xing J; Chen J; You T; Sun Z; Lu T; Cheng Y; Wu H; Bai C
    J Neuroendocrinol; 2023 Apr; 35(4):e13257. PubMed ID: 36964649
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Genomic portrait of resectable hepatocellular carcinomas: implications of RB1 and FGF19 aberrations for patient stratification.
    Ahn SM; Jang SJ; Shim JH; Kim D; Hong SM; Sung CO; Baek D; Haq F; Ansari AA; Lee SY; Chun SM; Choi S; Choi HJ; Kim J; Kim S; Hwang S; Lee YJ; Lee JE; Jung WR; Jang HY; Yang E; Sung WK; Lee NP; Mao M; Lee C; Zucman-Rossi J; Yu E; Lee HC; Kong G
    Hepatology; 2014 Dec; 60(6):1972-82. PubMed ID: 24798001
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Small-cell neuroendocrine carcinoma of the ileum: case report and literature review.
    Lee JE; Hong SH; Jung HI; Son MW; Ahn TS; Han SW; Cho JH
    BMC Surg; 2019 Sep; 19(1):135. PubMed ID: 31510991
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A Subset of Large Cell Neuroendocrine Carcinomas in the Gastroenteropancreatic Tract May Evolve from Pre-existing Well-Differentiated Neuroendocrine Tumors.
    Pelosi G; Bianchi F; Dama E; Metovic J; Barella M; Sonzogni A; Albini A; Papotti M; Gong Y; Vijayvergia N
    Endocr Pathol; 2021 Sep; 32(3):396-407. PubMed ID: 33433886
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Next generation sequencing of Cytokeratin 20-negative Merkel cell carcinoma reveals ultraviolet-signature mutations and recurrent TP53 and RB1 inactivation.
    Harms PW; Collie AM; Hovelson DH; Cani AK; Verhaegen ME; Patel RM; Fullen DR; Omata K; Dlugosz AA; Tomlins SA; Billings SD
    Mod Pathol; 2016 Mar; 29(3):240-8. PubMed ID: 26743471
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Microsatellite unstable gastrointestinal neuroendocrine carcinomas: a new clinicopathologic entity.
    Sahnane N; Furlan D; Monti M; Romualdi C; Vanoli A; Vicari E; Solcia E; Capella C; Sessa F; La Rosa S
    Endocr Relat Cancer; 2015 Feb; 22(1):35-45. PubMed ID: 25465415
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Analysis of clinically relevant somatic mutations in high-risk head and neck cutaneous squamous cell carcinoma.
    Zilberg C; Lee MW; Yu B; Ashford B; Kraitsek S; Ranson M; Shannon K; Cowley M; Iyer NG; Palme CE; Ch'ng S; Low TH; O'Toole S; Clark JR; Gupta R
    Mod Pathol; 2018 Feb; 31(2):275-287. PubMed ID: 28984303
    [TBL] [Abstract][Full Text] [Related]  

  • 80. REST Inactivation and Coexpression of ASCL1 and POU3F4 Are Necessary for the Complete Transformation of RB1/TP53-Inactivated Lung Adenocarcinoma into Neuroendocrine Carcinoma.
    Masawa M; Sato-Yazawa H; Kashiwagi K; Ishii J; Miyata-Hiramatsu C; Iwamoto M; Kohno K; Miyazawa T; Onozaki M; Noda S; Shimizu Y; Niho S; Yazawa T
    Am J Pathol; 2022 Jun; 192(6):847-861. PubMed ID: 35367201
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.